Literature DB >> 6370242

The heterogeneity of bovine growth hormone. Extraction from the pituitary of components with different biological and immunological properties.

I C Hart, L A Blake, P M Chadwick, G A Payne, A D Simmonds.   

Abstract

Bovine growth hormone (somatotropin) was extracted from anterior pituitaries and fractionated into four protein peaks (A-D) by chromatography on DEAE-Sephacel. Analysis by high-pressure liquid chromatography and sodium dodecyl sulphate/polyacrylamide-gel electrophoresis indicated that the homogeneity of the material increased from fraction A through to D. The properties of the fractions were examined in the following manner: immunological activity (radioimmunoassays for ruminant growth hormone and prolactin); growth-promoting activity (rat tibia test); lipolytic activity (release of glycerol from rat epididymal fat in the presence of dexamethasone); diabetogenic activity (rate of glucose transport in epididymal fat of hypophysectomized rats and intravenous insulin-tolerance tests in goats). None of the fractions contained immunoreactive prolactin and all were equally lipolytic. Although fraction A contained a small quantity of immunoreactive growth hormone it had no growth-promoting or diabetogenic activities. Both fractions B and C were diabetogenic and contained high concentrations of immunoreactive growth hormone, consistent with their growth-promoting activity. Although the growth-promoting activity of fraction D was higher than that of the other three fractions, it was not diabetogenic and was only weakly immunoreactive. These results for bovine growth hormone support the contention that growth hormone, as commonly extracted, is a mixture of different molecular forms and that these different metabolic properties of the hormone might be explained in terms of this heterogeneity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6370242      PMCID: PMC1153374          DOI: 10.1042/bj2180573

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  38 in total

1.  Bioassay of hypophyseal growth hormone; the tibia test.

Authors:  F S GREENSPAN; C H LI
Journal:  Endocrinology       Date:  1949-11       Impact factor: 4.736

2.  Enhancement of the hyperglycemic activity of human growth hormone by enzymic modification.

Authors:  U J Lewis; R N Singh; W P Vanderlaan; G F Tutwiler
Journal:  Endocrinology       Date:  1977-11       Impact factor: 4.736

3.  The relationship between the transport of glucose and cations across cell membranes in isolated tissues. V. Stimulating effect of ouabain, K+-free medium and insulin on efflux of 3-O-methylglucose from epidimal adipose tissue.

Authors:  T Clausen
Journal:  Biochim Biophys Acta       Date:  1969

4.  Molecular weight estimation of polypeptide chains by electrophoresis in SDS-polyacrylamide gels.

Authors:  A L Shapiro; E Viñuela; J V Maizel
Journal:  Biochem Biophys Res Commun       Date:  1967-09-07       Impact factor: 3.575

5.  Glucose transport in adipocytes and its control by growth hormone in vivo.

Authors:  E Schoenle; J Zapf; E R Froesch
Journal:  Am J Physiol       Date:  1982-06

6.  The relationship of the bovine pituitary "diabetogenic peptide" to prolactin.

Authors:  A D Rogol; F Grissom; R E Follows
Journal:  Horm Metab Res       Date:  1978-11       Impact factor: 2.936

7.  Large-scale preparation of highly purified pyrogen-free human growth hormone for clinical use.

Authors:  R L Jones; G Benker; P R Salacinski; T J Lloyd; P J Lowry
Journal:  J Endocrinol       Date:  1979-07       Impact factor: 4.286

8.  Endocrine control of energy metabolism in the cow: comparison of the levels of hormones (prolactin, growth hormone, insulin and thyroxine) and metabolites in the plasma of high- and low-yielding cattle at various stages of lactation.

Authors:  I C Hart; J A Bines; S V Morant; J L Ridley
Journal:  J Endocrinol       Date:  1978-06       Impact factor: 4.286

9.  Diabetogenic peptide from human growth hormone: partial purification from peptic digest and long-term action in ob/ob mice.

Authors:  A J Lostroh; M E Krahl
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

10.  Metabolic effects of the major component of bovine growth hormone.

Authors:  N I Swislocki; M Sonenberg; M Kikutani
Journal:  Biochem J       Date:  1971-05       Impact factor: 3.857

View more
  6 in total

Review 1.  Molecular heterogeneity of human GH: from basic research to clinical implications.

Authors:  C L Boguszewski
Journal:  J Endocrinol Invest       Date:  2003-03       Impact factor: 4.256

2.  A comparison of the growth-promoting, lipolytic, diabetogenic and immunological properties of pituitary and recombinant-DNA-derived bovine growth hormone (somatotropin).

Authors:  I C Hart; P M Chadwick; T C Boone; K E Langley; C Rudman; L M Souza
Journal:  Biochem J       Date:  1984-11-15       Impact factor: 3.857

3.  Formation of isoaspartate 99 in bovine and porcine somatotropins.

Authors:  B N Violand; M R Schlittler; P C Toren; N R Siegel
Journal:  J Protein Chem       Date:  1990-02

4.  Evidence from the use of monoclonal antibody probes for structural heterogeneity of the growth hormone receptor.

Authors:  R Barnard; P G Bundesen; D B Rylatt; M J Waters
Journal:  Biochem J       Date:  1985-10-15       Impact factor: 3.857

5.  Differential secretion of chicken growth hormone variants after growth hormone-releasing hormone stimulation in vitro.

Authors:  Hilda Martínez-Coria; L Javier López-Rosales; Martha Carranza; Laura Berumen; Maricela Luna; Carlos Arámburo
Journal:  Endocrine       Date:  2002-03       Impact factor: 3.925

6.  Growth Hormone and Insulin-like Growth Factor-I Molecular Weight Isoform Responses to Resistance Exercise Are Sex-Dependent.

Authors:  Joseph R Pierce; Brian J Martin; Kevin R Rarick; Joseph A Alemany; Jeffery S Staab; William J Kraemer; Wesley C Hymer; Bradley C Nindl
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-21       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.